Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers

NCT03654989 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped recruitment difficulties

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Treprostinil iontophoresis
DEVICE: Remodulin® placebo iontophoresis

Sponsor

University Hospital, Grenoble